Search
for
Sort by
Research 631–660 of 962
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Validation of a skin and coat scoring protocol in dogs
- Scalp Lifting
- Histopathological Findings and Proliferative Activity of Canine Sebaceous Gland Tumours with a Predominant Reserve Cell Population
- Two Dogs with Juvenile-Onset Skin Diseases with Involvement of Extremities
- Novel causes of drug-induced occupational asthma
- Eosinophilic granulomas in two dogs
- Short Scar Rhytidectomy Techniques
- Hypothyroidism in Dogs
- Mechanisms of Dermatophyte Invasion on New Zealand Rabbit Skin Models
- Effects of Post-Therapy Changes on the Level of Immunoglobulin M in Dogs with Dermatitis
- A Review on Cryptorchidism-Induced Alopecia in Dogs
- Prospect of Stem Cell Conditioned Medium in Regenerative Medicine
- Skin biopsy
- Pharmacology of antiandrogens
- Ubiquity and Diversity of Human-Associated Demodex Mites
- Toxicologic studies with the hypotensive agent minoxidil
- Study of<i>Demodex</i>mites: Challenges and Solutions
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Specialization and the Physician Workforce
- Androgen antagonists in androgen target tissues
- Potassium channel openers: therapeutic potential in cardiology and medicine
- The Effect of Mesenchymal Stem Cells and Chitosan Gel on Full Thickness Skin Wound Healing in Albino Rats: Histological, Immunohistochemical and Fluorescent Study
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Chemical Compatibility and Safety of Imidacloprid/Flumethrin Collar (Seresto®) Concomitantly Used with Imidacloprid/Moxidectin (Advocate®, Advantage® Multi) and Emodepside/Praziquantel (Profender®) Spot-on Formulations
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors